News
Focusing on Treatment Education this May for Skin Cancer Awareness Month
OncoBeta® GmbH, a global medical device company specialising in innovative therapies for non-melanoma skin cancers (NMSCs), is supporting World Skin…
Fully recruited EPIC-Skin international study for the treatment of Non-Melanoma Skin Cancer
Garching n. Munich, Germany – OncoBeta® GmbH, a medical device company specialised in innovative epidermal radioisotope therapies, has confirmed the…
Skin: Below the Surface
We are thrilled to announce our participation in the programme ‘Skin: Below the Surface’ by the British Skin Foundation in cooperation with ITN…
GenesisCare and OncoBeta announce partnership to provide innovative treatment for non-melanoma skin cancer
OncoBeta® GmbH and GenesisCare have partnered to offer a breakthrough treatment for non-melanoma skin cancer. This partnership addresses Australia's…
Patient Frank Pattison talks about his experience - Channel 9 News
Listen to what Frank and his daughter have to say about the wonderful results achieved with the Rhenium-SCT on a Basel-Cell-Carcinoma on his ear.
Rhenium-SCT Rostock Trial results to be presented at EANM
This year the last patient in the Rhenium-SCT Rostock Trial had his final, 12 month follow up visit at the University Clinic in Rostock
The team from…
German skin cancer patients join the EPIC-Skin study
Garching, Munich. Germany – OncoBeta® GmbH has announced University Clinic of Rostock (is particpating in the global phase IV EPIC-Skin Study (Effic…
Interview with Dr. Joe Cardaci: committee member of the international Registry
Dr. Joe Cardaci, committee member of the international Registry, tells us a bit about his experience with the Rhenium-SCT and this world-first…
Rhenium-SCT reached Canadian medical news in LePatient
The non-invasive, single-session treatment for non-melanoma skin cancer, Rhenium-SCT, reached Canadian medical news. Le Patient, distributed by the…
Perth skin cancer patients undergo first treatments with OncoBeta’s Rhenium-SCT as part of the EPIC-Skin study
Perth, Australia– OncoBeta® GmbH today announced Perth’s Hollywood Private Hospital in Australia is the latest medical facility to participate in the…